ALLISON TURNER: Open Payments
NPI 1023456076 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,973 in 44 payments from 7 companies in 2025. Trend: 2023 $3,991 · 2024 $1,256 · 2025 $4,973
Speaker / faculty: $3,858Food & beverage: $1,115
| Company | Payments | Amount |
|---|---|---|
| BIOTRONIK NRO, Inc. | 15 | $4,403 |
| Abbott Laboratories | 9 | $228 |
| Collegium Pharmaceutical, Inc. | 12 | $150 |
| Boston Scientific Corporation | 4 | $121 |
| SPR Therapeutics, Inc | 2 | $37 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
| ABBVIE INC. | 1 | $15 |
Products named: Prospera, PROCLAIM, Belbuca, Intracept, SPRINT PNS System, ETERNA, WaveWriter Alpha Prime 16, XTAMPZA.
Industry payments across TX — which companies pay providers there.
